Inventor
JONG SUNG KOH
Inventor
KR
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds32%
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C07BGeneral methods of organic chemistry11%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
PatentTitleYear
RE050528Compounds and compositions for modulating EGFR mutant kinase activities202512,258,3275-membered heteroaryl-containing aminopyridine compounds as EGFR inhibitors202512,064,426Selective inhibitors of ROCK1 and ROCK2 protein kinases and uses thereof202411,945,798Substituted aminopyridine compounds as EGFR inhibitors202411,731,969Crystal polymorph of 8-bromo-2-(1-methylpiperidin-4-ylamino)-4-(4-phenoxyphenylamino)pyrido[4,3-d]pyrimidin-5(6H)-one hydrochloride and method for preparing same202311,370,796Substituted pyrazoles as LRRK2 inhibitors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2023Patents assigned to OSCOTEC INC (2)· patent assignee history
2022–2025Based in KR· patent location history
2024–2025Patents assigned to YUHAN CORP (3)· patent assignee history
2024–2025Patents assigned to JANSSEN BIOTECH INC (2)· patent assignee history
2024Patents assigned to GENOSCO INC (1)· patent assignee history
2024–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| YUHAN CORP | 3 | 2024–2025 |
| JANSSEN BIOTECH INC | 2 | 2024–2025 |
| OSCOTEC INC | 2 | 2022–2023 |
| GENOSCO INC | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| KR | 3 | 2022–2025 |
| US | 3 | 2024–2025 |